Li, M., Al-Jamal, K.T., Kostarelos, K. and Reineke, J. (2010) Physiologically Based Pharmacokinetic Modeling of Nanoparticles. ACS Nano, 4 (11). pp. 6303-6317. 10.1021/nn1018818.
Full text not available from this repository.
Rapid expansion of nanoparticle research demands new technologies that will enable better interpretation of experimental data and assistance in the rational design of future nanoparticles. The use of physiologically based pharmacokinetic (PBPK) models may serve as powerful tools to meet these needs. PBPK models have been successfully applied for the study of the absorption, distribution, metabolism, and excretion (ADME) of small molecules, such as drugs. Preliminary application of PBPK models to nanoparticles illustrated their potential usefulness for nanoparticle ADME research. However, due to the differences between nanoparticles and small molecules, modifications are needed to build appropriate PBPK models for nanoparticles. This review is divided into two sections, with the first discussing nanoparticle ADME research, emphasizing the interaction of nanoparticles with living systems, including transportation kinetics across biobarriers. In the second section, the basic principles of PBPK model development are introduced, and research pertaining to PBPK models of nanoparticles is reviewed. Factors that need to be considered for developing PBPK models for nanoparticles are also discussed. Finally, perspective applications of nanoparticle PBPK models are summarized.
|Uncontrolled Keywords:||PBPK; nanoparticles; ADME; biodistribution; pharmacokinetics; mathematical simulation; toxicity|
|Departments, units and centres:||Department of Pharmaceutics > Centre for Drug Delivery Research|
|Journal or Publication Title:||ACS Nano|
|Deposited By:||Library Staff|
|Deposited On:||04 Mar 2011 08:40|
|Last Modified:||04 May 2012 11:23|
Item downloaded times since 04 Mar 2011 08:40.
Repository Staff Only: Item control page
School of Pharmacy Staff Only: Edit a copy to replace this item